Manchester BRC receives £4.4M investment to fight the growing threat of antibiotic resistance
Manchester is one of ten leading research centres across the country to receive funding to explore innovative new ways to inform prescribing and identify patterns of resistance. The investment will result in expansion of the NIHR Manchester Biomedical Research Centre’s (BRC’S) respiratory research. The respiratory infections programme of the BRC research is working towards earlier diagnosis and more targeted approach, which match an individual to the treatment most likely to provide the desired response.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.